31/10/2019 (Agence Europe) – The EU is contributing €6 million to clinical trials on an Ebola vaccine in the DRC, the European Commission announced on Thursday 31 October. This contribution is funded by the Horizon 2020 research programme. The aim is to try to contain the epidemic which is continuing to develop in the east of the country, with a risk of contagion to neighbouring countries. "The EU has supported the development of the new Ebola vaccine and we are in the process of deploying the clinical study in the Democratic Republic of Congo", says Research Commissioner Carlos Moedas. "The EU is determined to support the World Health Organisation and the DRC authorities in their efforts to fight the epidemic", confirms Christos Stylianides, Commissioner for Humanitarian Aid and Crisis Management. (AN)